Article cité par

La fonctionnalité Article cité par… liste les citations d'un article. Ces citations proviennent de la base de données des articles de EDP Sciences, ainsi que des bases de données d'autres éditeurs participant au programme CrossRef Cited-by Linking Program. Vous pouvez définir une alerte courriel pour être prévenu de la parution d'un nouvel article citant " cet article (voir sur la page du résumé de l'article le menu à droite).

Article cité :

Risk of Pregnancy Termination and Congenital Anomalies After Domperidone Exposure: A Study in the EFEMERIS Database

Mélanie Araujo, Clémentine Vabre, Justine Benevent, et al.
Drug Safety 44 (7) 787 (2021)
https://doi.org/10.1007/s40264-021-01077-9

Dispensing of Potentially Harmful Prescription Drugs in 1.8 Million Pregnant Women in France: A Nationwide Study Based on Two Risk Classification Systems

Pierre-Olivier Blotière, Christine Damase-Michel, Alain Weill and Géric Maura
Drug Safety 44 (12) 1323 (2021)
https://doi.org/10.1007/s40264-021-01117-4

Efficacy of phloroglucinol for the treatment of pain of gynaecologic or obstetrical origin: a systematic review of literature of randomised controlled trials

Blanchard Clara, Vanderkam Paul, Pouchain Denis, et al.
European Journal of Clinical Pharmacology 76 (1) 1 (2020)
https://doi.org/10.1007/s00228-019-02745-7

Prescription médicamenteuse chez la femme enceinte au centre de santé de référence de Koutiala en 2016

A.A. Oumar, A. Guindo, M. Sanogo, Y. Cissoko, N. Magassa, S.K. Coulibaly, S. Dao and S. Doumbia
Le Pharmacien Hospitalier et Clinicien 54 (4) 325 (2019)
https://doi.org/10.1016/j.phclin.2019.08.003

The French Pregnancy Cohort: Medication use during pregnancy in the French population

Anick Bérard, Fatima Abbas-Chorfa, Behrouz Kassai, et al.
PLOS ONE 14 (7) e0219095 (2019)
https://doi.org/10.1371/journal.pone.0219095

Drug use and its associated factors among pregnant women in Bahir Dar city administration, northwest Ethiopia

EW Mengesha
International Journal of Sexual and Reproductive Health Care 2 (1) 021 (2019)
https://doi.org/10.17352/ijsrhc.000007

Pharmacological Safety in Pregnancy: A Systematic Review On the Use of Potentially Teratogenic Drugs

Olga V. Reshetko, Konstantin A. Lutsevich and Irina I. Sanina
Pediatric pharmacology 14 (2) 127 (2017)
https://doi.org/10.15690/pf.v14i2.1727

Prescription drug use during pregnancy in France: a study from the national health insurance permanent sample

Romain Demailly, Sylvie Escolano, Catherine Quantin, Pascale Tubert‐Bitter and Ismaïl Ahmed
Pharmacoepidemiology and Drug Safety 26 (9) 1126 (2017)
https://doi.org/10.1002/pds.4265

Drug Use before and during Pregnancy in Japan: The Japan Environment and Children’s Study

Hidekazu Nishigori, Taku Obara, Toshie Nishigori, Hirohito Metoki, Mami Ishikuro, Satoshi Mizuno, Kasumi Sakurai, Nozomi Tatsuta, Ichiko Nishijima, Ikuma Fujiwara, Takahiro Arima, Kunihiko Nakai, Nariyasu Mano, Shinichi Kuriyama and Nobuo Yaegashi
Pharmacy 5 (2) 21 (2017)
https://doi.org/10.3390/pharmacy5020021

Médicaments et grossesse : une enquête menée auprès de 374 femmes en France

Aurélie Guérin, André Rieutord, Laurie Cuche, Angela Lupattelli and Hedvig Nordeng
Therapies 71 (6) 613 (2016)
https://doi.org/10.1016/j.therap.2016.04.005

Évaluation des médicaments chez la femme enceinte : à propos de la base de données française EFEMERIS

Christine Damase-Michel, Isabelle Lacroix, Caroline Hurault-Delarue, Anna-Belle Beau and Jean-Louis Montastruc
Therapies 69 (1) 91 (2014)
https://doi.org/10.2515/therapie/2014005

La cohorte des grossesses du Québec : prévalences et conséquences de l’utilisation des médicaments durant la grossesse

Anick Bérard and Odile Sheehy
Therapies 69 (1) 71 (2014)
https://doi.org/10.2515/therapie/2014011

Premières données épidémiologiques sur le phloroglucinol et exposition au cours du premier trimestre de grossesse

I. Lacroix, C. Hurault-Delarue, S. Kessler, et al.
Gynécologie Obstétrique & Fertilité 39 (12) 694 (2011)
https://doi.org/10.1016/j.gyobfe.2011.07.013

Prescription drug use during pregnancy in developed countries: a systematic review

Jamie R. Daw, Gillian E. Hanley, Devon L. Greyson and Steven G. Morgan
Pharmacoepidemiology and Drug Safety 20 (9) 895 (2011)
https://doi.org/10.1002/pds.2184

Pharmacoepidemiological research using French reimbursement databases: yes we can!

Karin Martin‐Latry and Bernard Bégaud
Pharmacoepidemiology and Drug Safety 19 (3) 256 (2010)
https://doi.org/10.1002/pds.1912

Vitamin, mineral and iron supplementation in pregnancy: cross-sectional study

M. Leppee, J. Culig, M. Eric, J. Boskovic and N. Colak
Biopolymers and Cell 26 (2) 128 (2010)
https://doi.org/10.7124/bc.00014F

Health care providers’ requests to Teratogen Information Services on medication use during pregnancy and lactation

Marie-Pierre Gendron, Brigitte Martin, Driss Oraichi and Anick Bérard
European Journal of Clinical Pharmacology 65 (5) 523 (2009)
https://doi.org/10.1007/s00228-008-0611-6

The association of psychosocial factors with nausea and vomiting during pregnancy

Gertraud E. Markl, Christine Strunz-Lehner, Veronika Egen-Lappe, Nicholas Lack and Joerg Hasford
Journal of Psychosomatic Obstetrics & Gynecology 29 (1) 17 (2008)
https://doi.org/10.1080/01674820701504528

Prescriptions et délivrances d’anti-inflammatoires non stéroïdiens après le 6e mois de grossesse : impact d’une lettre d’information envoyée par les autorités de santé

Caroline Hurault, Isabelle Lacroix, Robert Bourrel, Jean-Louis Montastruc and Christine Damase-Michel
La Presse Médicale 37 (5) 767 (2008)
https://doi.org/10.1016/j.lpm.2007.07.027

Drug-prescribing patterns during pregnancy in the tertiary care hospitals of Pakistan: a cross sectional study

Dileep K Rohra, Nirmal Das, Syed I Azam, et al.
BMC Pregnancy and Childbirth 8 (1) (2008)
https://doi.org/10.1186/1471-2393-8-24

Antimalarial drugs and pregnancy: safety, pharmacokinetics, and pharmacovigilance

Stephen A Ward, Esperanca JP Sevene, Ian M Hastings, François Nosten and Rose McGready
The Lancet Infectious Diseases 7 (2) 136 (2007)
https://doi.org/10.1016/S1473-3099(07)70025-7

Prescribing patterns of anti-emetic drugs during pregnancy in Germany

Gertraud E. Markl, Chirstine Strunz-Lehner, Veronika Egen-Lappe and Joerg Hasford
Archives of Gynecology and Obstetrics 275 (6) 461 (2007)
https://doi.org/10.1007/s00404-006-0286-0

Méthodes de surveillance et de gestion des risques des médicaments pour la future mère, l’embryon, le fœtus et le nouveau-né

Evelyne Jacqz-Aigrain, Véronique Lamarque, E. Autret-Leca, et al.
Therapies 61 (4) 287 (2006)
https://doi.org/10.2515/therapie:2006056

Antibiotics in pregnancy: analysis of potential risks and determinants in a large German statutory sickness fund population

Ute Amann, Veronika Egen‐Lappe, Christine Strunz‐Lehner and Joerg Hasford
Pharmacoepidemiology and Drug Safety 15 (5) 327 (2006)
https://doi.org/10.1002/pds.1225

Prevalence and patterns of antidepressant drug use during pregnancy

Tessa Ververs, Hans Kaasenbrood, Gerard Visser, et al.
European Journal of Clinical Pharmacology 62 (10) 863 (2006)
https://doi.org/10.1007/s00228-006-0177-0

Risk Management and Monitoring Methods for the Future Mother, Embryo, Fetus, and post-natal Consequences

Evelyne Jacqz-Aigrain, Véronique Lamarque, E. Autret-Leca, et al.
Therapies 61 (4) 297 (2006)
https://doi.org/10.2515/therapie:2006057

Drug prescription in pregnancy: analysis of a large statutory sickness fund population

Veronika Egen-Lappe and Joerg Hasford
European Journal of Clinical Pharmacology 60 (9) 659 (2004)
https://doi.org/10.1007/s00228-004-0817-1